Search research articles
Contact Us
Filters
Showing results (101-110 of 157) with videos related to
Page
of 16
Sort By:
SSM. Qualitative Research in Health
|
December 18, 2023
Pathways to care with HIV-associated cryptococcal meningitis in Botswana and Uganda: Findings from a qualitative methods study
David S Lawrence, Agnes Ssali, Neo Moshashane, et al.
ACS Synthetic Biology
|
December 14, 2019
Engineered BRET-Based Biologic Light Sources Enable Spatiotemporal Control over Diverse Optogenetic Systems
Kshitij Parag-Sharma, Colin P O'Banion, Erin C Henry, et al.
Social Science & Medicine (1982)
|
June 1, 2022
Decision making in a clinical trial for a life-threatening illness: Therapeutic expectation, not misconception
David S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Plos Neglected Tropical Diseases
|
October 24, 2022
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda
David S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Endocrinology
|
October 14, 2006
Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age
Christopher D Morrison, Christy L White, Zhong Wang, et al.
Angewandte Chemie (International Ed. in English)
|
June 7, 2005
Design, construction, and intracellular activation of an intramolecularly self-silenced signal transduction inhibitor
Seung-Yub Lee, Fubo Liang, Xiao-Ling Guo, et al.
Biochemistry
|
January 4, 2006
Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate
Hyangkyu Lee, Laiping Xie, Yong Luo, et al.
The Journal of Biological Chemistry
|
January 28, 2003
Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor
Jin-Peng Sun, Alexander A Fedorov, Seung-Yub Lee, et al.
The Lancet. HIV
|
May 2, 2024
Two-drug regimens for the treatment of HIV in Africa
Ivan Mambule, Claire Norcross, Loice Achieng Ombajo, et al.
Journal of Proteome Research
|
December 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Marissa L Cann, Laura E Herring, Lauren L Haar, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 157) with videos related to
Sort By:
Page
of 16
SSM. Qualitative Research in Health
|
December 18, 2023
Pathways to care with HIV-associated cryptococcal meningitis in Botswana and Uganda: Findings from a qualitative methods study
David S Lawrence, Agnes Ssali, Neo Moshashane, et al.
ACS Synthetic Biology
|
December 14, 2019
Engineered BRET-Based Biologic Light Sources Enable Spatiotemporal Control over Diverse Optogenetic Systems
Kshitij Parag-Sharma, Colin P O'Banion, Erin C Henry, et al.
Social Science & Medicine (1982)
|
June 1, 2022
Decision making in a clinical trial for a life-threatening illness: Therapeutic expectation, not misconception
David S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Plos Neglected Tropical Diseases
|
October 24, 2022
The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda
David S Lawrence, Agnes Ssali, Neo Moshashane, et al.
Endocrinology
|
October 14, 2006
Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age
Christopher D Morrison, Christy L White, Zhong Wang, et al.
Angewandte Chemie (International Ed. in English)
|
June 7, 2005
Design, construction, and intracellular activation of an intramolecularly self-silenced signal transduction inhibitor
Seung-Yub Lee, Fubo Liang, Xiao-Ling Guo, et al.
Biochemistry
|
January 4, 2006
Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate
Hyangkyu Lee, Laiping Xie, Yong Luo, et al.
The Journal of Biological Chemistry
|
January 28, 2003
Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor
Jin-Peng Sun, Alexander A Fedorov, Seung-Yub Lee, et al.
The Lancet. HIV
|
May 2, 2024
Two-drug regimens for the treatment of HIV in Africa
Ivan Mambule, Claire Norcross, Loice Achieng Ombajo, et al.
Journal of Proteome Research
|
December 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Marissa L Cann, Laura E Herring, Lauren L Haar, et al.
Page
of 16